Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.4.1.2 (
glutamate dehydrogenase
)
4,380
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cells of Euglena gracilis
Klebs
strain z Pringsheim had high NADP-dependent
glutamate dehydrogenase
activity when grown on glutamate as nitrogen source but activity was completely repressed in cells grown on ammonium (NH4+). A 120-fold purification of NADPH-
glutamate dehydrogenase
(subunit Mr = 45 000) was achieved from glutamate-grown cells by affinity chromatography on blue Sepharose CL-6B. Antisera raised against the homogeneously pure protein were used to demonstrate that increase in NADPH-
glutamate dehydrogenase
activity on transfer from NH4+ to glutamate medium resulted from an increase in the amount of protein. Glutamate NH4+-grown cells were labelled with L-[35S]methionine and anti-(NADPH-
glutamate dehydrogenase
) used to immunoprecipitate the dehydrogenase from cell extracts. NADPH-
glutamate dehydrogenase
protein was detected in glutamate-grown but not NH4+-grown cells. Anti-(NADPH-
glutamate dehydrogenase
) was used to detect NADPH-
glutamate dehydrogenase
resulting from the translation of total polyadenylated RNA from Euglena in a cell-free rabbit reticulocyte lysate system. NADPH-glutamate dehydrogenase mRNA was present in glutamate NH4+-grown cells, there being no apparent difference in mRNA abundance between cells showing a tenfold difference in NADPH-
glutamate dehydrogenase
specific activity. These results indicate that the synthesis of this dehydrogenase is regulated primarily at the post-transcriptional level.
...
PMID:Glutamate dehydrogenase (NADP-dependent) mRNA in relation to enzyme synthesis in Euglena gracilis. Evidence for post-transcriptional control. 286 58